MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Inhibiting transgene expression with a tissue-specific microRNA target ameliorates AAV vector toxicity in NHPs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These results further suggest that the differences in signalling observed between CAG and hAAT-carrying vectors in vitro are due to expression of the transgene similar to what has been reported in the context of DRG toxicity 38 .”
From AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain (2025) · cites this paper as [38]
In the citing paper
“Previous work has suggested a role for transgene over-expression in DRG toxicity 38 .”
From AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain (2025) · cites this paper as [38]
In the citing paper
“possibility of alternative, non-immune-mediated toxicity such as dorsal root ganglion toxicity with AAV9 (110)”
From Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies (2021) · cites this paper as [110]
In the citing paper
“For example, AAV-mediated gene delivery into the CNS of pigs or non-human primates causes dorsal root ganglion toxicity that is alleviated by reducing or deleting transgene expression.38,39,66”
From An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission (2024) · cites this paper as [39]
In the citing paper
“Despite an overall strong safety profile, AAV-mediated gene delivery has been associated with neurotoxicity in specific cell populations, some of which can be attributed to the overexpressed transgene.”
From An innate immune response to adeno-associated virus genomes decreases cortical dendritic complexity and disrupts synaptic transmission (2024) · cites this paper as [39]
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G.-P., Wilson, J. M., & Batshaw, M. L. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.016 · Cited by 1,498
Self-citationClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 1×
“At the turn of the century, researchers found a family of endogenous AAVs that, as vectors, achieved much higher transduction efficiencies while retaining favorable safety profiles (2).”
BackgroundSelf-citationDistribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968 · cited 1×
“Under normal conditions, expression of this complex is largely restricted to neurons of the olfactory epithelium, ear, retina, and DRG as demonstrated in zebrafish (23), mouse (24–26), rat (27), and human tissues (24, 28).”
BackgroundHinderer, C., Katz, N., Buza, E. L., Dyer, C., Goode, T., Bell, P., Richman, L. K., & Wilson, J. M. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.015 · Cited by 814
Self-citationHoggan, M. D., Blacklow, N. R., & Rowe, W. P. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1467 · Cited by 536
Brown, B. D., Venneri, M. A., Zingale, A., Sergi, L. S., & Naldini, L. (2006) · Nature Medicine · doi:10.1038/nm1398 · Cited by 484 · cited 1×
“We used an approach previously deployed for restricting lentiviral vector expression in hematopoietic-derived cells (20) or detargeting the liver, heart, or muscle after AAV-mediated gene transfer (21, 22).”
MethodXu, S., Witmer, P. D., Lumayag, S., Kovacs, B., & Valle, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700501200 · Cited by 474
MicroRNA expression in the adult mouse central nervous system
Bak, M., Silahtaroglu, A., Møller, M., Christensen, M., Rath, M. F., Skryabin, B., Tommerup, N., & Kauppinen, S. (2008) · RNA · doi:10.1261/rna.783108 · Cited by 463
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Hordeaux, J., Wang, Q., Katz, N., Buza, E. L., Bell, P., & Wilson, J. M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.018 · Cited by 426 · cited 1×
“Our studies in nonhuman primates (NHPs) showed acute development of thrombocytopenia and transaminitis, which, in some cases, evolved into a lethal syndrome of hemorrhage and shock (9, 10).”
BackgroundSelf-citationKapsimali, M., Kloosterman, W. P., de Bruijn, E., Rosa, F., Plasterk, R. H., & Wilson, S. W. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r173 · Cited by 376 · cited 1×
“DRG-enriched miRNA sequences were selected through a literature search [miR183 cluster (27, 29, 39) and miR145 (30)], and their sequences were obtained on the public database www.”
MethodZhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376 · cited 1×
“In contrast to nonviral and adenoviral vectors, which elicit vibrant acute inflammatory responses (3, 4), AAV vectors are not proinflammatory.”
BackgroundSelf-citationRapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at Scale
Lock, M., Alvira, M., Vandenberghe, L. H., Samanta, A., Toelen, J., Debyser, Z., & Wilson, J. M. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.055 · Cited by 334 · cited 1×
“AAV vectors were produced and titrated by the Penn Vector Core as described previously (37).”
MethodSelf-citationAdeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
Hordeaux, J., Buza, E. L., Dyer, C., Goode, T., Mitchell, T. W., Richman, L., Denton, N., Hinderer, C., Katz, N., Schmid, R., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.167 · Cited by 257 · cited 3×
“Our total experience of adolescent/adult NHPs administered AAV vectors into the CSF via ICM or lumbar puncture (LP) route totals 219 monkeys spanning 27 studies (19) that encompass previously Fig.”
BackgroundSelf-citationMingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254
Regulation of Apoptosis by the Unfolded Protein Response
Fribley, A., Zhang, K., & Kaufman, R. J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-017-5_14 · Cited by 221 · cited 1×
“The UPR triggers ATF6 activation in the Golgi to generate cytosolic fragments, which migrate to the nucleus to activate the transcription of endoplasmic reticulum–associated binding elements (33); apoptosis via the UPR occurs through the intrinsic pathway (33).”
BackgroundThe microRNA-183 cluster: the family that plays together stays together
Dambal, S., Shah, M., Mihelich, B., & Nonn, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv703 · Cited by 214
Lock, M., Alvira, M. R., Chen, S.-J., & Wilson, J. M. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.131 · Cited by 163 · cited 1×
“The purified vectors were titrated with a droplet digital PCR using primers targeting the rabbit -globin polyadenylate sequence as previously described (38).”
MethodSelf-citationAldrich, B. T., Frakes, E. P., Kasuya, J., Hammond, D. L., & Kitamoto, T. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.033 · Cited by 147 · cited 2×
“DRG-enriched miRNA sequences were selected through a literature search [miR183 cluster (27, 29, 39) and miR145 (30)], and their sequences were obtained on the public database www.”
BackgroundMethodmiR-183 cluster scales mechanical pain sensitivity by regulating basal and neuropathic pain genes
Peng, C., Li, L., Zhang, M.-D., Bengtsson Gonzales, C., Parisien, M., Belfer, I., Usoskin, D., Abdo, H., Furlan, A., Häring, M., et al. (2017) · Science · doi:10.1126/science.aam7671 · Cited by 142
The Complex and Evolving Story of T cell Activation to AAV Vector-encoded Transgene Products
Mays, L. E., & Wilson, J. M. (2011) · Molecular Therapy · doi:10.1038/mt.2010.250 · Cited by 125
Self-citationHordeaux, J., Hinderer, C., Goode, T., Katz, N., Buza, E. L., Bell, P., Calcedo, R., Richman, L. K., & Wilson, J. M. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.06.003 · Cited by 105 · cited 6×
“3 of 14 published toxicology studies (15, 16) and the two NHP experiments described below, as well as a number of unpublished studies.”
BackgroundMethodSelf-citationGao, G., Wang, Q., Calcedo, R., Mays, L., Bell, P., Wang, L., Vandenberghe, L. H., Grant, R., Sanmiguel, J., Furth, E. E., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.060 · Cited by 103
Self-citationMicroRNA-regulated viral vectors for gene therapy
Geisler, A., & Fechner, H. (2016) · World Journal of Experimental Medicine · doi:10.5493/wjem.v6.i2.37 · Cited by 93 · cited 1×
“We used an approach previously deployed for restricting lentiviral vector expression in hematopoietic-derived cells (20) or detargeting the liver, heart, or muscle after AAV-mediated gene transfer (21, 22).”
MethodGolebiowski, D., van der Bom, I. M. J., Kwon, C.-S., Miller, A. D., Petrosky, K., Bradbury, A. M., Maitland, S., Kühn, A. L., Bishop, N., Curran, E., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.109 · Cited by 87
Neonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman primates
Hinderer, C., Bell, P., Louboutin, J.-P., Zhu, Y., Yu, H., Lin, G., Choa, R., Gurda, B. L., Bagel, J., O'Donnell, P., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.99 · Cited by 85 · cited 1×
“Antibodies to hIDUA were measured in serum (1:1000 sample dilution) as previously described (44).”
MethodSelf-citationHordeaux, J., Hinderer, C., Goode, T., Buza, E. L., Bell, P., Calcedo, R., Richman, L. K., & Wilson, J. M. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.06.004 · Cited by 81 · cited 4×
“However, strong immune suppression regimens such as MMF and rapamycin did not prevent the toxicity in toxicology studies (15, 16), nor did steroids in this study.”
BackgroundSelf-citationHordeaux, J., Hinderer, C., Buza, E. L., Louboutin, J.-P., Jahan, T., Bell, P., Chichester, J. A., Tarantal, A. F., & Wilson, J. M. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.012 · Cited by 76 · cited 1×
“The only experiment where we did not see DRG toxicity in NHPs after ICM injection was when the vector was administered to 1-month-old macaques that were necropsied 4 years later (35).”
BackgroundSelf-citationIdentification and target prediction of miRNAs specifically expressed in rat neural tissue
Hua, Y.-J., Tang, Z.-Y., Tu, K., Zhu, L., Li, Y.-X., Xie, L., & Xiao, H.-S. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-214 · Cited by 72 · cited 17×
“Animals received high-dose intravenous injections of AAV9 to target DRGs or high-dose AAV-PHP.”
BackgroundMethodInfluentialZhang, H.-Y., Zheng, S., Zhao, J., Zhao, W., Zheng, L., Zhao, D. Y., Li, J., Zhang, X., Chen, Z., & Yi, X. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.067 · Cited by 71
Assessment of Humoral, Innate, and T-Cell Immune Responses to Adeno-Associated Virus Vectors
Calcedo, R., Chichester, J. A., & Wilson, J. M. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2018.038 · Cited by 62
Self-citationGreig, J. A., Peng, H., Ohlstein, J., Medina-Jaszek, C. A., Ahonkhai, O., Mentzinger, A., Grant, R. L., Roy, S., Chen, S.-J., Bell, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112268 · Cited by 55
Self-citationRegulatory and Exhausted T Cell Responses to AAV Capsid
Gernoux, G., Wilson, J. M., & Mueller, C. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.022 · Cited by 44
Self-citationKatz, N., Goode, T. L., Hinderer, C. J., Hordeaux, J., & Wilson, J. M. (2018) · Human Gene Therapy Methods · doi:10.1089/hgtb.2018.041 · Cited by 27 · cited 1×
“hIDUA vectors in a total volume of 1 ml of sterile artificial CSF (vehicle) injected into the cisterna magna, under fluoroscopic guidance as previously described (40).”
MethodSelf-citationGenomic non-redundancy of the mir-183/96/182 cluster and its requirement for hair cell maintenance
Fogerty, J., Stepanyan, R., Cianciolo, L. T., Tooke, B. P., & Perkins, B. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-46593-y · Cited by 11
Flanigan, K. M., Simmons, T. R., McBride, K. L., Kunkler, K. L., Alyward, S., Couce, M. L., Oreiro, M. T., Smith, N. J. C., Jaensch, L., Fuller, M., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.12.122 · Cited by 2
Research works printed but not linked: 2
- Pfizer (2019); https://investors.pfizer.com/investor-news/press-release-details/2019/Pfizer-Presents-Initial-Clinical-Data-on-Phase-1b-Gene-Therapy-Study-for-Duchenne-Muscular-Dystrophy-DMD/default.aspx.
- V. Kumar A. K. Abbas J. C. Aster Robbins and Cotran Pathologic Basis of Disease (Elsevier Saunders Philadelphia 2015) pp. 31–68.
Cited by
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
“443 Another potential mitigating strategy is to target the peptide processing and MHC presentation pathway.”
BackgroundGoertsen, D., Flytzanis, N. C., Goeden, N., Chuapoco, M. R., Cummins, A., Chen, Y., Fan, Y., Zhang, Q., Sharma, J., Duan, Y., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-021-00969-4 · Cited by 420
Immunogenicity and toxicity of AAV gene therapy
Ertl, H. C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975803 · Cited by 402
AAV-based in vivo gene therapy for neurological disorders
Ling, Q., Herstine, J. A., Bradbury, A., & Gray, S. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00766-7 · Cited by 197
Gene therapy for ALS: A review
Amado, D. A., & Davidson, B. L. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.008 · Cited by 184
“Recent studies successfully used DRG-specific miRNAs to downregulate transgene expression in these cells while preserving intended CNS transduction, an efficient detargeting strategy that can be employed across any AAV-based therapeutic.(126) Finally, one notable study used a novel subpial delivery method, administeri…”
Method
Metadata
- Authors
- Hordeaux, J., Buza, E. L., Jeffrey, B., Song, C., Jahan, T., Yuan, Y., Zhu, Y., Bell, P., Li, M., Chichester, J. A., Calcedo, R., & Wilson, J. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Wilson, James M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-11-11
- Volume
- 12
- Issue
- 569
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3104217413
- Cited by
- 174
- References
- 39
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 32 · 2023: 37 · 2022: 26 · 2021: 25 · 2020: 1
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania Gene Therapy Program
- Orphan Disease Center (MPS-19-001-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus vectors, microRNA-183, transgene expression regulation, 3' untranslated region, non-human primates, central nervous system gene therapy, neurotoxicity, cisterna magna injection, steroid immunosuppression
- MeSH terms
- Dependovirus, Animals, Ganglia, Spinal, Genetic Vectors, Primates, Transduction, Genetic, Gene Transfer Techniques, Transgenes, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.